NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Medicine & Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine & Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Abbott



New findings from the United States and Canada in the area of hypertension described



October 13th, 2006

Investigators in the United States and Canada have published new hypertension data.

Study 1: Endothelin type A receptors maintain the hypertension produced by endothelin type B blockade.

Scientists in the United States report, "The net contribution of endothelin type A (ETA) and type B (ETB) receptors in blood pressure regulation in humans and experimental animals, including the conscious mouse, remains undefined. Thus we assessed the role of ETA and ETB receptors in the control of basal blood pressure and also the role of ETA receptors in maintaining the hypertensive effects of systemic ETB blockade in telemetry-instrumented mice."

...


Source: Medicine & Law Weekly (2006-10-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login